Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021 (Q80656129)
Jump to navigation
Jump to search
scientific article published on 23 July 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021 |
scientific article published on 23 July 2007 |
Statements
Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021 (English)
Elaine Abrams
Adriana Weinberg
Coleen Cunningham
Ross E McKinney
John Rodman
Chengcheng Hu
Paula Britto
Michael Hughes
Mary Elizabeth Smith
Leslie K Serchuck
Joyce Kraimer
Alberto A Ortiz
Patricia Flynn
Ram Yogev
Stephen Spector
Linda Draper
Paul Tran
Melissa Scites
Ruth Dickover
M Robert Blum
Gregory E Chittick
Laurie Reynolds
Mobeen Rathore
Pediatric AIDS Clinical Trials Group Protocol P1021 Study Team